Guardian Pharmacy Services Inc

Guardian Pharmacy Services Inc (GRDN) Stock Analysis

$39.680

-0.881 (-2.22%)At close

Loading chart…
High
41.215
Open
40.870
VWAP
40.05
Volume
444.00K
Mkt Cap
—
Low
39.260
Amount
17.78M
EV/EBITDA, TTM
32.15

Guardian Pharmacy Services, Inc. is a pharmacy services company. The Company provides a range of technology-enabled services designed to help residents of long-term care facilities (LTCFs) adhere to drug regimen. It offers compliance packaging service for repackaging and dispensing prescription and non-prescription pharmaceuticals in accordance with physician orders and delivers the medications to LTCFs for administration to individual residents. It organizes each resident’s medications into individual unit dose or multi-unit dose packaging in accordance with specific drug distribution rounds that occur at LTCFs at specific times throughout the day. Its pharmacy workflow software helps to manage and track drug dispensing via a structured and scalable workflow process, including the use of barcode technology. It offers Guardian Compass, which includes dashboards created to help local pharmacies plan, track and optimize business operations.

AI analysis of Guardian Pharmacy Services Inc (GRDN)

Buy

Guardian Pharmacy Services Inc is a good buy right now, as it has a current price of $41.28, significantly below the analyst consensus target of $49.81, indicating a potential upside of approximately 20.8%. Additionally, the company reported a gross margin of 22.75% in Q2 2026, reflecting strong profitability. The main risk is the recent 5-day change of -2.60%, indicating short-term volatility.

Valuation Metrics

The current forward P/E ratio for Guardian Pharmacy Services Inc (GRDN) is 30.21, compared to its 5-year average forward P/E of 26.68.

Forward P/E

Fair
5Y Average P/E
26.68
Current P/E
30.21
Overvalued
30.51
Undervalued
22.84

Forward EV/EBITDA

Strongly Overvalued
5Y Average EV/EBITDA
18.14
Current EV/EBITDA
32.15
Overvalued
23.66
Undervalued
12.62

Forward P/S

Overvalued
5Y Average P/S
1.27
Current P/S
1.64
Overvalued
1.55
Undervalued
0.99

Whales holding GRDN

A

Aristotle Capital Boston, LLC

+ HoldingGRDN

+0.13%

3M Return

Events Timeline

2026-09-01 (ET)

17:00:00

Guardian Pharmacy Acquires Assets from Nautilus Pharmacy

2026-08-06 (ET)

17:01:00

Raises FY26 Adjusted EBITDA View to $129M-$131M

17:01:00

Guardian Reports Q2 Revenue of $351.8M, Beating Expectations

2026-07-01 (ET)

17:00:00

Guardian Pharmacy Acquires Wellness Concepts to Expand Virginia Operations

2026-06-22 (ET)

17:00:00

Guardian Pharmacy Executive Forbes Retires, Morris to Become COO

News

GRDN FAQ — answered by Alphio AI

Guardian Pharmacy Services, Inc. is a pharmacy services company. The Company provides a range of technology-enabled services designed to help residents of long-term care facilities (LTCFs) adhere to drug regimen. It offers compliance packaging service for repackaging and dispensing prescription and non-prescription pharmaceuticals in accordance with physician orders and delivers the medications to LTCFs for administration to individual residents. It organizes each resident’s medications into individual unit dose or multi-unit dose packaging in accordance with specific drug distribution rounds that occur at LTCFs at specific times throughout the day. Its pharmacy workflow software helps to manage and track drug dispensing via a structured and scalable workflow process, including the use of barcode technology. It offers Guardian Compass, which includes dashboards created to help local pharmacies plan, track and optimize business operations. It operates in the Consumer Non-Cyclicals sector.

Guardian Pharmacy Services Inc is a good buy right now, as it has a current price of $41.28, significantly below the analyst consensus target of $49.81, indicating a potential upside of approximately 20.8%. Additionally, the company reported a gross margin of 22.75% in Q2 2026, reflecting strong profitability. The main risk is the recent 5-day change of -2.60%, indicating short-term volatility.

Community

More ↗

No posts yet

Sign up or log in to join the discussion

This page is for research only and is not investment advice. Models can be wrong. Past performance does not guarantee future results.

Start trading